MetLife Investment Management’s Zymeworks ZYME Stock Holding History

MetLife Investment Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$743K	Buy	29,653 +1,023	+4%	+$24.2K	﹤0.01%	1557
2025 Q4	$754K	Sell	28,630 -4,679	-14%	-$102K	﹤0.01%	1589
2025 Q3	$569K	Hold	33,309	–	–	﹤0.01%	1744
2025 Q2	$418K	Hold	33,309	–	–	﹤0.01%	1767
2025 Q1	$397K	Sell	33,309 -637	-2%	-$8.69K	﹤0.01%	1832
2024 Q4	$497K	Buy	33,946 +2,053	+6%	+$28.7K	﹤0.01%	1801
2024 Q3	$400K	Hold	31,893	–	–	﹤0.01%	1901
2024 Q2	$271K	Buy	31,893 +2,995	+10%	+$26.7K	﹤0.01%	2055
2024 Q1	$304K	Hold	28,898	–	–	﹤0.01%	1953
2023 Q4	$300K	Hold	28,898	–	–	﹤0.01%	2002
2023 Q3	$183K	Hold	28,898	–	–	﹤0.01%	2268
2023 Q2	$250K	Buy	+28,898	New	+$259K	﹤0.01%	2139

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MetLife Investment Management's ZYME Position: Q1 2026 in Review

MetLife Investment Management increased its Zymeworks (ZYME) stake by 3.6% in Q1 2026, buying an estimated $24.2K and bringing the position to 29,653 shares worth $743K. The position accounts for ﹤0.01% of the portfolio, ranked #1557.

MetLife Investment Management first reported a position in ZYME in Q2 2023 and has held it in 12 quarters since. The position peaked at $754K in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

MetLife Investment Management held 29,653 shares of Zymeworks worth $743K as of Q1 2026.
MetLife Investment Management bought 1,023 Zymeworks shares in Q1 2026, an estimated $24.2K.
Zymeworks made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1557 holding.
MetLife Investment Management first reported a position in Zymeworks in Q2 2023 and has held it in 12 quarters since.
MetLife Investment Management's Zymeworks position peaked at $754K in Q4 2025.
211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.